KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Net Margin (2016 - 2025)

Boston Scientific (BSX) has disclosed Net Margin for 17 consecutive years, with 12.71% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 33.0% to 12.71% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14.44% through Dec 2025, up 337.0% year-over-year, with the annual reading at 14.44% for FY2025, 337.0% up from the prior year.
  • Net Margin hit 12.71% in Q4 2025 for Boston Scientific, down from 14.91% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 15.75% in Q2 2025 to a low of 2.56% in Q4 2021.
  • Historically, Net Margin has averaged 10.0% across 5 years, with a median of 11.51% in 2021.
  • Biggest five-year swings in Net Margin: surged 2017bps in 2021 and later crashed -868bps in 2022.
  • Year by year, Net Margin stood at 2.56% in 2021, then soared by 52bps to 3.89% in 2022, then soared by 249bps to 13.56% in 2023, then fell by -9bps to 12.39% in 2024, then rose by 3bps to 12.71% in 2025.
  • Business Quant data shows Net Margin for BSX at 12.71% in Q4 2025, 14.91% in Q3 2025, and 15.75% in Q2 2025.